NYSE : MRK

Merck & Co., Inc. — Financial statements

Healthcare · Drug Manufacturers - General · United States

Last price 149.52 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 368.89B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Merck & Co., Inc. (MRK) reported revenue of 67.38B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue67.38B65.01B64.17B60.12B59.28B48.70B
Cost of Revenue15.56B14.81B14.70B15.91B17.21B13.47B
Gross Profit51.82B50.20B49.47B44.20B42.08B35.24B
Selling, General & Admin10.84B10.12B10.10B9.88B9.67B9.40B
Research & Development30.84B15.61B14.48B18.34B11.92B11.94B
Operating Expenses41.68B25.73B24.58B28.23B21.59B21.34B
Operating Income10.14B24.47B24.89B15.97B20.49B13.89B
Interest Expense-1.96B-1.36B-1.27B-1.15B-962.00M-806.00M
Interest & Investment Income191.00M343.00M415.00M365.00M157.00M36.00M
Currency Exchange Gain (Loss)-237.00M-323.00M-227.00M-370.00M-237.00M-297.00M
Other Non Operating Income (Expenses)155.00M203.00M290.00M419.50M681.00M256.00M
EBT Excluding Unusual Items8.29B23.33B24.10B15.24B20.13B13.08B
Merger & Restructuring Charges-2.74B-2.63B-4.34B-12.34B-666.00M-868.00M
Gain (Loss) on Sale of Investments616.00M368.00M14.00M340.00M-1.42B1.94B
Asset Writedown-779.00M-1.60B-275.00M
Legal Settlements-572.50M
Other Unusual Items-1.40B170.00M
Pretax Income4.76B21.07B19.94B1.89B16.44B13.88B
Income Tax Expense2.31B2.80B2.80B1.51B1.92B1.52B
Earnings From Continuing Operations2.45B18.26B17.13B377.00M14.53B12.36B
Earnings From Discontinued Operations704.00M
Net Income to Company2.45B18.26B17.13B377.00M14.53B13.06B
Minority Interest in Earnings4.00M-9.00M-16.00M-12.00M-7.00M-13.00M
Net Income2.45B18.25B17.12B365.00M14.52B13.05B
Net Income to Common2.45B18.25B17.12B365.00M14.52B13.05B
Shares Outstanding (Basic)2.47B2.50B2.53B2.54B2.53B2.53B
Shares Outstanding (Diluted)2.47B2.51B2.54B2.55B2.54B2.54B
EPS (Basic)0.997.306.760.145.735.16
EPS (Diluted)0.997.286.740.145.715.14
Free Cash Flow12.36B18.10B9.14B14.71B9.66B
Free Cash Flow Per Share4.937.123.595.793.81
Dividend Per Share3.363.243.082.922.762.60
Gross Margin76.91%77.21%77.09%73.53%70.98%72.35%
Operating Margin15.05%37.64%38.79%26.57%34.56%28.52%
Profit Margin3.64%28.08%26.67%0.61%24.49%26.79%
Free Cash Flow Margin19.01%28.20%15.21%24.81%19.84%
EBITDA15.96B29.11B29.13B19.71B24.28B17.02B
EBITDA Margin23.69%44.77%45.40%32.78%40.95%34.94%
D&A For EBITDA5.82B4.64B4.25B3.73B3.79B3.12B
EBIT10.14B24.47B24.89B15.97B20.49B13.89B
EBIT Margin15.05%37.64%38.79%26.57%34.56%28.52%
Effective Tax Rate48.57%13.31%14.06%80.04%11.66%10.96%
Advertising Expenses2.30B2.40B2.30B2.20B2.00B

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents14.56B13.24B6.84B12.69B8.10B
Short-Term Investments447.00M252.00M498.00M
Cash & Short-Term Investments7.14B14.56B13.69B7.09B13.19B8.10B
Accounts Receivable12.69B11.12B11.07B10.62B10.78B
Other Receivables15.00M8.00M
Receivables12.71B11.13B11.07B10.62B10.78B
Inventory6.66B6.11B6.36B5.91B5.95B
Restricted Cash125.00M76.00M68.00M79.00M71.00M
Other Current Assets9.46B7.78B7.58B5.92B5.37B
Total Current Assets43.52B38.78B32.17B35.72B30.27B
Property, Plant & Equipment26.82B25.15B24.49B22.77B20.86B
Long-Term Investments2.08B1.61B1.56B2.44B966.00M
Goodwill21.58B21.67B21.20B21.20B21.26B
Other Intangible Assets26.68B16.37B18.01B20.27B22.93B
Long-Term Accounts Receivable125.00M
Long-Term Deferred Tax Assets2.60B3.60B1.97B503.00M692.00M
Other Long-Term Assets13.46B9.93B7.29B6.25B8.71B
Total Assets136.87B117.11B106.67B109.16B105.69B
Accounts Payable4.51B5.00B4.43B5.16B6.39B
Accrued Expenses13.74B13.98B14.13B12.51B11.49B
Short-Term Debt289.00M149.00M72.00M246.00M112.00M
Current Portion of Long-Term Debt2.30B2.50B1.30B1.70B2.30B
Current Portion of Leases294.00M282.00M285.00M281.00M304.00M
Current Income Taxes Payable4.73B3.91B2.65B1.99B1.22B
Other Current Liabilities2.46B2.59B2.82B2.36B2.05B
Total Current Liabilities28.33B28.42B25.69B24.24B23.87B
Long-Term Debt46.75B34.46B33.68B28.75B30.69B
Long-Term Leases901.00M877.00M928.00M1.01B1.23B
Pension & Post-Retirement Benefits839.00M939.00M1.23B1.22B1.87B
Long-Term Deferred Tax Liabilities1.44B1.39B871.00M1.79B3.44B
Other Long-Term Liabilities5.95B4.65B6.63B6.09B6.34B
Total Liabilities84.20B70.73B69.04B63.10B67.44B
Common Stock1.79B1.79B1.79B1.79B1.79B
Additional Paid-In Capital45.03B44.70B44.51B44.38B44.24B
Retained Earnings73.08B63.07B53.90B61.08B53.70B
Treasury Stock-63.00B-58.30B-57.45B-56.49B-57.11B
Comprehensive Income & Other-4.29B-4.95B-5.16B-4.77B-4.43B
Total Common Equity41.93B52.61B46.31B37.58B45.99B38.18B
Minority Interest56.00M59.00M54.00M67.00M73.00M
Shareholders' Equity41.98B52.66B46.37B37.63B46.06B38.26B
Total Liabilities & Equity136.87B117.11B106.67B109.16B105.69B
Total Debt53.91B50.53B38.27B36.27B31.98B34.63B
Net Cash (Debt)-46.77B-35.97B-24.58B-29.18B-18.79B-26.54B
Net Cash Per Share-18.90-14.35-9.67-11.45-7.39-10.46
Filing Date Shares Outstanding2.48B2.47B2.53B2.53B2.54B2.53B
Total Common Shares Outstanding2.48B2.47B2.53B2.53B2.54B2.53B
Working Capital15.19B10.36B6.47B11.48B6.39B
Book Value Per Share16.9921.2618.3214.8418.1215.11
Tangible Book Value-4.63B4.35B8.28B-1.63B4.52B-6.01B
Tangible Book Value Per Share-1.871.763.27-0.641.78-2.38
Land321.00M307.00M326.00M295.00M326.00M
Buildings17.98B16.36B14.97B13.17B12.53B
Machinery19.76B18.28B17.76B16.76B16.30B
Construction In Progress9.17B7.98B8.26B9.19B8.31B

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income18.25B17.12B365.00M14.52B13.05B
Depreciation & Amortization4.64B4.25B3.73B3.79B3.12B
Asset Writedown & Restructuring Costs1.25B293.00M932.00M1.87B393.00M
Loss (Gain) on Equity Investments-368.00M-14.00M-340.00M1.42B-1.94B
Stock-Based Compensation820.00M761.00M645.00M541.00M479.00M
Other Operating Activities-1.15B2.73B9.88B-260.00M1.86B
Change in Accounts Receivable-1.09B-244.00M-1.15B-644.00M-2.03B
Change in Inventory-1.18B-835.00M-816.00M-161.00M-674.00M
Change in Accounts Payable110.00M182.00M-380.00M-289.00M405.00M
Change in Income Taxes137.00M1.02B214.00M380.00M-540.00M
Change in Other Net Operating Assets-4.95B-3.79B-75.00M-2.07B-997.00M
Operating Cash Flow16.47B21.47B13.01B19.09B14.11B
Capital Expenditures-4.11B-3.37B-3.86B-4.39B-4.45B
Cash Acquisitions-10.04B-4.09B-12.03B-12.91B
Investment in Securities471.00M-142.00M1.85B-483.00M1.02B
Other Investing Activities-58.00M-127.00M-36.00M-89.00M-225.00M
Investing Cash Flow-13.74B-7.73B-14.08B-4.96B-16.55B
Long-Term Debt Issued13.88B3.60B5.94B7.94B
Total Debt Issued13.88B3.60B5.94B7.94B
Short-Term Debt Repaid-3.99B
Long-Term Debt Repaid-2.50B-1.29B-1.75B-2.25B-2.32B
Total Debt Repaid-2.50B-1.29B-1.75B-2.25B-6.30B
Net Debt Issued (Repaid)11.38B2.31B4.18B-2.25B1.63B
Issuance of Common Stock92.00M177.00M125.00M384.00M202.00M
Repurchase of Common Stock-5.08B-1.31B-1.35B-840.00M
Common Dividends Paid-8.18B-7.84B-7.45B-7.01B-6.61B
Other Financing Activities-131.00M-372.00M-328.00M-240.00M8.21B
Financing Cash Flow-1.92B-7.03B-4.81B-9.12B2.59B
Foreign Exchange Rate Adjustments563.00M-293.00M23.00M-410.00M-133.00M
Net Cash Flow1.37B6.41B-5.86B4.61B14.00M
Free Cash Flow12.36B18.10B9.14B14.71B9.66B
Free Cash Flow Margin19.01%28.20%15.21%24.81%19.84%
Free Cash Flow Per Share4.937.123.595.793.81
Levered Free Cash Flow11.89B17.83B9.26B12.64B5.43B
Unlevered Free Cash Flow12.73B18.62B9.98B13.24B5.93B
Cash Interest Paid1.30B1.30B1.10B937.00M779.00M
Cash Income Tax Paid6.09B3.93B4.34B3.24B2.41B
Change in Working Capital-6.98B-3.67B-2.21B-2.78B-3.84B

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization368.89B261.26B251.65B276.26B281.30B193.59B
Enterprise Value415.66B284.47B275.24B302.41B300.54B210.06B
Last Close Price149.52103.1393.94100.2199.2166.39
PE Ratio151.2214.3114.70756.8819.3814.84
Forward PE17.4712.1811.0517.4715.4510.97
PS Ratio5.474.023.924.604.753.98
PB Ratio8.804.965.437.346.115.06
P/TBV Ratio60.1230.4162.26
P/FCF Ratio22.9721.1413.9130.2119.1320.04
P/OCF Ratio18.4815.8611.7221.2414.7313.72
PEG Ratio3.401.260.271.211.500.97
EV/Sales Ratio6.174.384.295.035.074.31
EV/EBITDA Ratio26.049.779.4515.3512.3812.35
EV/EBIT Ratio40.9811.6311.0618.9314.6715.12
EV/FCF Ratio25.8823.0215.2133.0820.4321.74
Debt / Equity Ratio1.280.960.820.960.690.91
Debt / EBITDA Ratio3.291.711.301.811.301.99
Debt / FCF Ratio4.092.123.972.173.58
Net Debt / Equity Ratio1.110.680.530.780.410.69
Net Debt / EBITDA Ratio2.931.240.841.480.771.56
Net Debt / FCF Ratio2.911.363.191.282.75
Asset Turnover0.510.570.560.550.49
Inventory Turnover2.322.362.592.902.34
Quick Ratio0.960.870.710.980.79
Current Ratio1.541.361.251.471.27
Return on Equity (ROE)36.88%40.79%0.90%34.46%38.82%
Return on Assets (ROA)12.04%13.90%9.25%11.92%8.80%
Return on Invested Capital (ROIC)5.88%26.58%31.05%4.84%27.92%21.41%
Return on Capital Employed (ROCE)22.50%28.10%19.70%24.10%17.00%
Earnings Yield0.66%6.99%6.80%0.13%5.16%6.74%
FCF Yield4.35%4.73%7.19%3.31%5.23%4.99%
Dividend Yield2.27%3.07%3.09%2.68%2.49%3.40%
Payout Ratio343.87%44.79%45.80%2,039.73%48.30%50.65%
Buyback Yield / Dilution1.77%1.34%0.24%-0.20%-0.16%0.12%
Total Shareholder Return4.04%4.41%3.33%2.48%2.33%3.51%